infarct, acute Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Unknown (1)

Observational (1)

Foundation of Cardiovascular Research and Education Enschede (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadstenosis

I am/have/hadpercutaneous coronary intervention

I am/have/hadglucose intolerance

I am/have/hadmyocardial infarction

I am/have/hadclinical syndromes

I am/have/hadangina pectoris

I am/have/hadclinical syndrome

I am/have/haddiabetes

I am/have/hadprediabetes

I am/have/hadacute coronary syndrome

I am/have/hadunstable angina

I am/have/hadinfarct

I am/have/hadcoronary artery stenosis

added new label for I am/have/had

more

I am looking for

I am looking foreverolimus

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

For Seniors
For adults
Recruiting in 1000s
Observational Study
all
Cardiovascular Diseases
Recruiting

Complex All-comers and Patients With Diabetes or Prediabetes Treated With Xience Sierra Everolimus-eluting Stents

Drug eluting stents (DES) are widely used for treatment of coronary artery lesions. The Xience Sierra stent has a refined design of the metal stent backbone and is used in patients with various clinical syndromes and in different lesions. Clinical outcome of patients with previously unknown (silent) diabetes and prediabetes …

stenosis

percutaneous coronary intervention

glucose intolerance

myocardial infarction

everolimus

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.